IP Library Granted Patent US 10,588,999
Granted Patent B2
US 10,588,999 · App. 15/790,384 · Granted Mar 17, 2020

Mesoporous surface for enhanced bone integration

Inventors: Nader Montazemezam Kalkhoran (Tewksbury, MA); Eric Tobin (North Andover, MA); Jason Burns (Cambridge, MA)
Assignee: N2 BIOMEDICAL LLC
A61L27/10A61L27/06A61L27/306A61L27/54A61L27/56A61F2002/0086A61K47/02A61L2400/12A61L2400/18A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,588,999
App. No.
15/790,384
Granted
Mar 17, 2020
Kind
B2
Abstract

Techniques for creating a mesoporous surface for enhanced bone integration are provided. An example of a method for generating a mesoporous surface on a substrate includes depositing a layer of titanium on an area of the substrate to generate a nano-textured surface, and anodizing the layer of titanium on the area of the substrate to generate the mesoporous surface. The method may also include incorporating pharmaceutical, biological, or molecular additives into the mesoporous surface intended to further enhance performance of the substrate via enhanced osseoconduction, osseoinduction, or antimicrobial/anti-infective properties.

Claims (14)

1. A method for generating a mesoporous surface on a substrate, comprising:

grit-blasting an area of the substrate to generate a macro-textured surface;

depositing a layer of titanium on the area of the substrate to generate a nano-textured surface; and

anodizing the layer of titanium on the area of the substrate to generate the mesoporous surface.

2. The method of claim 1 wherein the substrate comprises a polyetheretherketone (PEEK) material.

3. The method of claim 1 wherein grit-blasting the area of the substrate includes air-blasting the area with 50-100 μm in diameter micro-beads of SiO 2 or Al 2 O 3 .

4. The method of claim 1 further comprising incorporating pharmaceutical, biological, or molecular additives into the mesoporous surface intended to further enhance performance of the substrate via enhanced osseoconduction, osseoinduction, or antimicrobial/anti-infective properties.

5. The method of claim 1 comprising depositing the layer of titanium on the area of the substrate with an ion beam assisted deposition (IBAD) process.

6. The method of claim 5 wherein the IBAD process utilizes an ion beam energy between 50 eV and 5000 eV.

7. The method of claim 1 wherein the layer of titanium is between 0.5 μm to 10 μm thick.

8. The method of claim 1 wherein anodizing the layer of titanium on the area of the substrate includes an electrochemical oxidation process in a hydrofluoric (HF) acid-based solution.

9. The method of claim 1 wherein anodizing the layer of titanium on the area of the substrate includes an electrochemical oxidation process in an ammonium fluoride (NH 4 F) acid-based solution.

10. The method of claim 1 wherein anodizing the layer of titanium on the area of the substrate includes an electrochemical oxidation process in a solution of nitric acid, hydrochloric acid, acetic acid, trichloroacetic acid, phosphoric acid, sulfuric acid, potassium hydroxide, sodium hydroxide, or combinations thereof.

11. The method of claim 1 wherein the mesoporous surface comprises pore sizes of between 1-50 nanometers in a lateral dimension and between 10-500 nanometers in depth.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: KEYSTONE DURA- N2 LLC
To: GREATBATCH LTD.
Reel/Frame 070398/0369 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2025
From: N2 BIOMEDICAL LLC
To: KEYSTONE DURA- N2 LLC
Reel/Frame 070287/0191 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2025
From: DURALECTRA-CHN, LLC; SANFORD PROCESS CORPORATION; N2 BIOMEDICAL LLC; KEYSTONE DURA- N2 LLC
To: GREATBATCH LTD.
Reel/Frame 070133/0765 →
SECURITY AGREEMENT Recorded Feb 28, 2022
From: N2 BIOMEDICAL LLC
To: HANCOCK WHITNEY BANK, AS ADMIN. AGENT
Reel/Frame 059474/0992 →
SECURITY INTEREST Recorded Jun 14, 2019
From: N2 BIOMEDICAL LLC
To: MIDDLESEX SAVINGS BANK
Reel/Frame 049466/0192 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2019
From: KALKHORAN, NADER MONTAZEMEZAM; TOBIN, ERIC; BURNS, JASON
To: N2 BIOMEDICAL LLC
Reel/Frame 049300/0681 →
Continuity (2)
Provisional Application 62411853 · Oct 24, 2016
Related Publication 20180110898A1 · Apr 26, 2018